title: Our experiences in kidney transplantation and monitoring of kidney graft outcomes.
abstract: Aim of kidney transplantation is to keep the functions of graft as long as possible, with an improvement of survival and quality of patients' lives. Aim of this article was to show the outcome of kidney transplantation in patients who were treated and monitored on Institute of Nephrology, CCU of Sarajevo in period between 1996 and 2004. and to identify the factors which can interfere with graft surviving. Retrospective analysis of data from the register of kidney transplanted patients was done. In the mentioned period 29 kidney transplants were performed, and at the same time 15 previously transplanted patients (total of 44) were monitored. Patients were followed until death or graft insufficiency. Most often cause of chronic renal failure before the transplantation were glomerular diseases (31.8% cases), and chronic pyelonephritis in 29.5% cases. Living-donor related kidney transplantation was performed in 56,8% of patients, living-donor unrelated in 27,3% of patients and cadaveric in 15.9% of patients. Post-transplant complications occurred in 29,5% of patients. Analysis of graft surviving on 12 months, 5 years and 10 years monitoring showed functional grafts in 87.5%, 80% and 75.0% of patients. Cumulative survival of patients on one year monitoring is 100%, on 5 year 100%, and on 10 year 93.8%. Primary causes of graft function loss were recurrent kidney diseases. Three patients (6.8%) died due to concomitant diseases, irrespective of the transplantation. Kidney transplantation is a successful treatment of a chronic renal failure with a high percentage of patients survival and long term graft survival, but also with serious post-transplant complications.
authors.affiliation: Institute of Nephrology, Clinical Center University of SarajevoBolnicka 25, 71 000 Sarajevo, Bosnia and Herzegovina.
authors.forename: Rasić
authors.initials: R
authors.lastname: Senija
authors.forename: Dzemidzić
authors.initials: D
authors.lastname: Jasminka
authors.forename: Aganović
authors.initials: A
authors.lastname: Kenana
authors.forename: Aganović
authors.initials: A
authors.lastname: Damir
authors.forename: Prcić
authors.initials: P
authors.lastname: Alden
mesh_terms: D000328:Adult; D017522:Bosnia and Herzegovina / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents